When.com Web Search

  1. Ads

    related to: ashland foundry chemicals

Search results

  1. Results From The WOW.Com Content Network
  2. Ashland Global - Wikipedia

    en.wikipedia.org/wiki/Ashland_Global

    Ashland announced plans to acquire Hercules, Inc. on July 11, 2008, for $3.3B. [20] On November 13, 2008, the transaction was completed. [21] In July 2010 Ashland merged its foundry chemicals activity with Süd-Chemie of Munich, Germany, to form ASK Chemicals L.P. with headquarters in Dublin, Ohio.

  3. Solenis - Wikipedia

    en.wikipedia.org/wiki/Solenis

    2014–Present: Ashland Water Technologies was bought by private investment firm Clayton, Dubilier & Rice (CD&R) from Ashland Inc. on July 31, 2014, and rebranded as Solenis. [7] 2008-2014: Ashland purchased Hercules Inc. in 2008 for $2.6 billion to double earnings and gain chemicals used in papermaking, water treatment and construction. [8]

  4. Rhône Group - Wikipedia

    en.wikipedia.org/wiki/Rhône_Group

    In April 2014, Rhône Group acquired the German ASK Chemicals (JV of Ashland Inc. and Swiss based Clariant). The deal was valued at about $350 million. [74] ASK Chemicals is a leading foundry chemicals manufacturer with nearly 2,000 employees in 25 countries.

  5. Hercules Inc. - Wikipedia

    en.wikipedia.org/wiki/Hercules_Inc.

    Hercules, Inc. was a chemical and munitions manufacturing company based in Wilmington, Delaware, United States, incorporated in 1912 as the Hercules Powder Company following the breakup of the DuPont explosives monopoly by the U.S. Circuit Court in 1911. [1]

  6. Jacqueline K. Barton - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/jacqueline-k-barton

    From January 2008 to December 2012, if you bought shares in companies when Jacqueline K. Barton joined the board, and sold them when she left, you would have a -17.6 percent return on your investment, compared to a -2.8 percent return from the S&P 500.

  7. Trump faces pressure from US industry over China tariff on ...

    www.aol.com/news/trump-faces-pressure-us...

    President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports, as they join big pharma lobbyists who have ...